CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Planned sale President and CEO sold 25,000 shares at an average $263.17 ($6,579,164)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 750 shares at $267.60 ($200,700)
- 4 Shares withheld for taxes President, R&D gave up 30,584 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 30,584 shares (to pay taxes)
- 4 Planned sale Director sold 11,803 shares at an average $275.59 ($3,252,824)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 60,161 shares at an average $268.44 ($16,149,383)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 18,950 shares at an average $261.41 ($4,953,694)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Planned sale Chief Accounting Officer sold 12,500 shares at an average $272.14 ($3,401,705)
- 144 Insider Sale of Securities
Page 3 of 26 · 513 filings